Prostate cancer

PRESTO (GETUG-AFU 36)

Prostate-cancer treatment using stereotactic radiotherapy for oligometastases;ablation in hormone-sensitive patients À a GETUG-AFU phase III randomized controlled trial

Open at Paris since : 01/07/2021
Target : Adult
Phase : Phase III

Trial description

To assess the efficacy of ablative radiotherapy (SBRT applied to all;oligometastases) administered to all gross tumor sites (metastases +/- prostate), in oligometastatic;hormone-sensitive prostate cancer patients.

Main investigator

GILLES CREHANGE

Professeur - Médecin

Contact